Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1
Open accessAbstract
This study examines endothelin-induced modulation of extracellular matrix synthesis and remodeling by fibroblasts, and its potential role in the pathogenesis of systemic sclerosis (scleroderma). Endothelin-1 promoted fibroblast synthesis of collagen types I and III, but not fibronectin, by a mechanism dependent upon both ETA and ETB receptors. Conversely, endothelin-1 inhibited both protein expression of matrix metalloproteinase 1 and zymographic activity exclusively via ETA receptors. A dual regulatory role for endothelin-1 in transcriptional regulation was suggested by the ability of endothelin-1 to enhance steady-state levels of collagen mRNA and activate the proalpha2(I) collagen (Col1a2) promoter, but in contrast to reduce matrix metalloproteinase 1 transcript expression and suppress transcription of a human matrix metalloproteinase 1 promoter reporter construct in transient transfection assays. Although endothelin-1 significantly enhanced remodeling of three-dimensional collagen lattices populated by normal fibroblasts, this was not observed for lattices populated by systemic sclerosis fibroblasts. Promotion of matrix remodeling was dependent upon ETA receptor expression and was blocked by specific inhibitors of tyrosine kinases or protein kinase C. Reverse transcriptase polymerase chain reaction, S1 nuclease, and functional cell surface binding studies showed that normal and systemic sclerosis fibroblasts express both ETA and ETB receptors (predominantly ETA), but that ETA receptor mRNA levels and ETA binding sites on fibroblasts cultured from systemic sclerosis skin biopsies are reduced by almost 50%. Endothelin-1 is thus able to induce a fibrogenic phenotype in normal fibroblasts that is similar to that of lesional systemic sclerosis fibroblasts. Moreover, reduced responsiveness to exogenous endothelin-1 in systemic sclerosis suggests that downstream pathways may have already been activated in vivo. These data further implicate dysregulated endothelin-receptor pathways in fibroblasts in the pathogenesis of connective tissue fibrosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Differentially regulated genes included vascular wall mediators such as COL4A1, COL3A1, and FN1.
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
From A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression (2017) · cites this paper as Shi-Wen et al., 2001
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,240 · see citing works
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczyński, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 47,092 · see citing works
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,925 · see citing works
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,661 · see citing works
Fibroblasts, myofibroblasts, and wound contraction
Grinnell, F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.401 · Cited by 1,141 · see citing works
Levin, E. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508103330607 · Cited by 711 · see citing works
LeRoy, E. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107827 · Cited by 543 · see citing works
Hocher, B., Thöne‐Reineke, C., Rohmeiss, P., Schmager, F., Slowinski, T., Burst, V. R., Siegmund, F., Quertermous, T., Bauer, C., Neumayer, H.-H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119297 · Cited by 408 · see citing works
Langholz, O., Roeckel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., & Eckes, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1903 · Cited by 397 · see citing works
Barton, M., Haudenschild, C. C., d’Uscio, L. V., Shaw, S., Münter, K., & Lüscher, T. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14367 · Cited by 356 · see citing works
Effects of endothelins on collagen turnover in cardiac fibroblasts
Eduardo Guarda, S., Katwa, L. C., Myers, P. R., Tyagi, S. C., & Weber, K. T. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2130 · Cited by 291 · see citing works
Vancheeswaran, R., Magoulas, T., Efrat, G., Wheeler-Jones, C. P. D., Olsen, I., Penny, R., & Black, C. M. (1994) · PubMed · Cited by 239 · see citing works
Kahaleh, M. B. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340807 · Cited by 234 · see citing works
Rockey, D. C., Fouassier, L., Chung, J. J., Carayon, A., Vallee, P. A. L., Rey, C., & Housset, C. (1998) · Hepatology · doi:10.1002/hep.510270222 · Cited by 231 · see citing works
Carvalho, D., Savage, C. O. S., Black, C. M., & Pearson, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118377 · Cited by 222 · see citing works
Abraham, D., Vancheeswaran, R., Dashwood, M. R., Rajkumar, V. S., Pantelides, P., Xu, S. W., du Bois, R. M., & Black, C. M. (1997) · Europe PMC (PubMed Central) · Cited by 211 · see citing works
The Role of α1β1 Integrin in Wound Contraction
Racine-Samson, L., Rockey, D. C., & Bissell, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30911 · Cited by 176 · see citing works
Jiménez, S. A., Feldman, G. M., Bashey, R. I., Bienkowski, R. S., & Rosenbloom, J. (1986) · Biochemical Journal · doi:10.1042/bj2370837 · Cited by 169 · see citing works
Localization of endothelin-1 and its binding sites in scleroderma skin.
Vancheeswaran, R., Azam, A., Black, C. M., & Dashwood, M. R. (1994) · PubMed · Cited by 125 · see citing works
Regulation of Endothelin-1 Synthesis by Endothelin-converting Enzyme-1 during Wound Healing
Shao, R., Yan, W., & Rockey, D. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3228 · Cited by 92 · see citing works
Mm, G., & Madhok, R. (1996) · PubMed · Cited by 83 · see citing works
Pagotto, U., Arzberger, T., Hopfner, Ú., Sauer, J., Renner, U., NEWTON, C. J., Lange, M., Uhl, E., Weindl, A., & Stalla, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118249 · Cited by 73 · see citing works
Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts.
Guidry, C., & Höök, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.3.873 · Cited by 68 · see citing works
Ivarsson, M., McWhirter, A., Black, C. M., & Rubin, K. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12364810 · Cited by 59 · see citing works
Endothelin-1 Induces Increased Fibronectin Expression in Human Bronchial Epithelial Cells
Marini, M. A., Carpi, S., Bellini, A., Patalano, F., & Mattoli, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0502 · Cited by 57 · see citing works
Biology of the scleroderma fibroblast
Strehlow, D., & Korn, J. H. (1998) · Current Opinion in Rheumatology · doi:10.1097/00002281-199811000-00011 · Cited by 57 · see citing works
Mutsaers, S. E., Marshall, R. P., Goldsack, N., Laurent, G. J., & McAnulty, R. J. (1998) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.1998.0142 · Cited by 55 · see citing works
Ichiki, Y., Smith, E. A., LeRoy, E. C., & Trojanowska, M. E. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613617 · Cited by 31 · see citing works
Takeda, S., 澤芳樹, Minami, M., Kaneda, Y., Fujii, Y., Shirakura, R., Yanagisawa, M., & Matsuda, H. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00367-6 · Cited by 30 · see citing works
Smith, P., Teichert-Kuliszewska, K., Monge, J. C., & Stewart, D. J. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199800001-00045 · Cited by 26 · see citing works
Scleroderma fibroblast phenotype is modulated by endothelial cell co-culture.
Denton, C. P., Xu, S., Welsh, K. I., Pearson, J. D., & Black, C. M. (1996) · PubMed · Cited by 21 · see citing works
Impaired Growth Response to Endothelin-1 in Scleroderma Fibroblasts
Kikuchi, K., Kadono, T., Sato, S., Tamaki, K., & Takehara, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1261 · Cited by 18 · see citing works
Blais (1997) · doi:10.1002/1529-0131(199707)40:7
Flagged first, then by citations
2 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Brown, K. K., Raghu, G., du Bois, R. M., Lynch, D. A., Martinez, F., Valeyre, D., Leconte, I., Morganti, A., Roux, S., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201011-1874oc · Cited by 718 · see citing works
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 662 · see citing works
The endothelin system in pulmonary arterial hypertension
Galiè, N. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.026 · Cited by 517 · see citing works
BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Lancaster, L., de Andrade, J. A., Stähler, G., Leconte, I., Roux, S., & Raghu, G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-732oc · Cited by 500 · see citing works
Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.049 · Cited by 450 · see citing works
Pathophysiology of systemic sclerosis: current understanding and new insights
Cutolo, M., Soldano, S., & Smith, V. M. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1614915 · Cited by 369 · see citing works
Shiwen, X., Chen, Y., Denton, C. P., Eastwood, M., Renzoni, E. A., Bou–Gharios, G., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Black, C. M., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0902 · Cited by 354 · see citing works
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M. J. C., Lau, E., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 340 · see citing works
Cardiac fibrosis: new insights into the pathogenesis
Ma, Z., Yuan, Y., Wu, H., Zhang, X., & Tang, Q. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.28103 · Cited by 333 · see citing works
Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
Iglarz, M., Binkert, C., Morrison, K., Fischli, W., Gatfield, J., Treiber, A., Weller, T., Bolli, M. H., Boss, C., Buchmann, S., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142976 · Cited by 326 · see citing works
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Piera-Velázquez, S., Mendoza, F. A., & Jiménez, S. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040045 · Cited by 276 · see citing works
Pulmonary hypertension in interstitial lung disease: Fig. 1—
Behr, J., & Ryu, J. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00171307 · Cited by 263 · see citing works
Selman, M., Thannickal, V. J., Pardo, A., Zisman, D. A., Martínez, F. J., & Lynch, J. P. (2004) · Drugs · doi:10.2165/00003495-200464040-00005 · Cited by 243 · see citing works
Overview of pathogenesis of systemic sclerosis
Abraham, D., Krieg, T. M., Distler, J. H. W., & Distler, O. (2006) · Rheumatology · doi:10.1093/rheumatology/ken481 · Cited by 243 · see citing works
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
Williams, M. H. (2005) · Heart · doi:10.1136/hrt.2005.069484 · Cited by 236 · see citing works
Endothelin—Biology and disease
Khimji, A.-K., & Rockey, D. C. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.002 · Cited by 222 · see citing works
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, Ó., García-Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shiwen, X., Carreira, P. E., Fontaine, B. A., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 192 · see citing works
Mechanisms of skin fibrosis in systemic sclerosis
Jinnin, M. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00738.x · Cited by 174 · see citing works
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK
Shiwen, X., Howat, S., Renzoni, E. A., Holmes, A. M., Pearson, J. D., Dashwood, M. R., Bou–Gharios, G., Denton, C. P., du Bois, R. M., Black, C. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311430200 · Cited by 173 · see citing works
How does endothelial cell injury start? The role of endothelin in systemic sclerosis
Abraham, D., & Distler, O. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2186 · Cited by 166 · see citing works
Shiwen, X., Kennedy, L., Renzoni, E. A., Bou–Gharios, G., du Bois, R. M., Black, C. M., Denton, C. P., Abraham, D., & Leask, A. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23134 · Cited by 163 · see citing works
Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis
Sakkas, L. I., Chikanza, I. C., & Platsoucas, C. D. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0346 · Cited by 162 · see citing works
Human Fibrotic Diseases: Current Challenges in Fibrosis Research
Rosenbloom, J., Macarak, E. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7113-8_1 · Cited by 157 · see citing works
Shiwen, X., Rodríguez‐Pascual, F., Lamas, S., Holmes, A. M., Howat, S., Pearson, J. D., Dashwood, M. R., du Bois, R. M., Denton, C. P., Black, C. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00625-06 · Cited by 156 · see citing works
Kulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 153 · see citing works
Enhanced Myofibroblastic Differentiation and Survival in Thy-1(−) Lung Fibroblasts
Sanders, Y. Y., Kumbla, P. A., & Hagood, J. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0178oc · Cited by 153 · see citing works
The role of endothelin-1 in pulmonary arterial hypertension
Chester, A. H., & Yacoub, M. H. (2014) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2014.29 · Cited by 149 · see citing works
Fibrosis and immune dysregulation in systemic sclerosis
Chizzolini, C., Brembilla, N. C., Montanari, E., & Truchetet, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.016 · Cited by 147 · see citing works
Seibold, J. R., Denton, C. P., Furst, D. E., Guillevin, L., Rubin, L. J., Wells, A. U., Matucci‐Cerinic, M., Riemekasten, G., Emery, P., Chadha‐Boreham, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27466 · Cited by 143 · see citing works
Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
Aden, N., Nuttall, A., Shiwen, X., de Winter, P., Leask, A., Black, C. M., Denton, C. P., Abraham, D., & Stratton, R. J. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.120 · Cited by 135 · see citing works
Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan
Clozel, M., & Salloukh, H. (2005) · Annals of Medicine · doi:10.1080/07853890410018925 · Cited by 135 · see citing works
Targeting the TGFβ, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma
Leask, A. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.01.006 · Cited by 125 · see citing works
Jiménez, S. A. (2013) · ISRN Rheumatology · doi:10.1155/2013/835948 · Cited by 127 · see citing works
Endothelin and endothelin receptor antagonists in systemic rheumatic disease
Mayes, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10895 · Cited by 125 · see citing works
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
Enevoldsen, F. C., Sahana, J., Wehland, M., Grimm, D. G., Infanger, M., & Krüger, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030824 · Cited by 121 · see citing works
Role of endothelin and endothelin receptor antagonists in renal disease
Neuhofer, W., & Pittrow, D. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01689.x · Cited by 119 · see citing works
IPF: new insight on pathogenesis and treatment
Harari, S. A., & Caminati, A. (2010) · Allergy · doi:10.1111/j.1398-9995.2009.02305.x · Cited by 119 · see citing works
Cipriani, P., Benedetto, P. D., Ruscitti, P., Capece, D., Zazzeroni, F., Liakouli, V., Pantano, I., Berardicurti, O., Carubbi, F., Pecetti, G., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.150088 · Cited by 117 · see citing works
Shiwen, X., Renzoni, E. A., Kennedy, L., Howat, S., Chen, Y., Pearson, J. D., Bou–Gharios, G., Dashwood, M. R., du Bois, R. M., Black, C. M., et al. (2007) · Matrix Biology · doi:10.1016/j.matbio.2007.06.003 · Cited by 116 · see citing works
Is systemic sclerosis an antigen‐driven T cell disease?
Sakkas, L. I., & Platsoucas, C. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20315 · Cited by 116 · see citing works
Lunardi, C., Dolcino, M., Peterlana, D., Bason, C., Navone, R., Tamassia, N., Beri, R., Corrocher, R., & Puccetti, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030002 · Cited by 113 · see citing works
Role of endothelin in the cardiovascular system
Rodríguez‐Pascual, F., Busnadiego, Ó., Lagares, D., & Lamas, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.014 · Cited by 112 · see citing works
Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx
Garsen, M., Lenoir, O., Rops, A. L. W. M. M., Dijkman, H. B. P. M., Willemsen, B. K., Kuppevelt, T. H. V., Rabelink, T. J., Berden, J. H. M., Tharaux, P., & van der Vlag, J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015091070 · Cited by 112 · see citing works
Anti-endothelial cell antibodies in systemic sclerosis
Mihai, C., & Tervaert, J. W. C. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102400 · Cited by 107 · see citing works
Interstitial Lung Disease in Idiopathic Inflammatory Myopathy
Saketkoo, L. A., Ascherman, D. P., Cottin, V., Christopher‐Stine, L., Danoff, S. K., & Oddis, C. V. (2010) · Current Rheumatology Reviews · doi:10.2174/157339710791330740 · Cited by 106 · see citing works
Pulmonary hypertension in systemic sclerosis
Denton, C. P., & Black, C. M. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00024-3 · Cited by 97 · see citing works
Opitz, C. F., Ewert, R., Kirch, W., & Pittrow, D. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn234 · Cited by 96 · see citing works
Current perspectives on the immunopathogenesis of systemic sclerosis
Fuschiotti, P. (2016) · ImmunoTargets and Therapy · doi:10.2147/itt.s82037 · Cited by 95 · see citing works
Ocular Manifestations of Scleroderma
Tailor, R., Gupta, A., Herrick, A. L., & Kwartz, J. (2009) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2008.12.007 · Cited by 90 · see citing works
Signalling and regulation of collagen I synthesis by ET‐1 and TGF‐β1
Horstmeyer, A., Licht, C. P. B., Scherr, G., Eckes, B., & Krieg, T. M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05016.x · Cited by 88 · see citing works
Sulli, A., Soldano, S., Pizzorni, C., Montagna, P., Secchi, M. E., Villaggio, B., SERIOLO, B., Brizzolara, R., & Cutolo, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081030 · Cited by 85 · see citing works
At the heart of tissue: endothelin system and end-organ damage
Iglarz, M., & Clozel, M. (2010) · Clinical Science · doi:10.1042/cs20100222 · Cited by 83 · see citing works
The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?
Rodríguez‐Pascual, F., Busnadiego, Ó., & González, J. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.12.024 · Cited by 83 · see citing works
Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis
Horowitz, J. C., Ajayi, I. O., Kulasekaran, P., Rogers, D. S., White, J. B. R., Townsend, S. K., White, E. S., Nho, R. S., Higgins, P., Huang, S. K., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.011 · Cited by 78 · see citing works
Matsushima, H., Yamada, N., Matsue, H., & Shimada, S. (2004) · European Journal of Immunology · doi:10.1002/eji.200424912 · Cited by 78 · see citing works
Cellular and molecular events leading to renal tubulointerstitial fibrosis
Razzaque, M. S., & Taguchi, T. (2002) · Medical Molecular Morphology · doi:10.1007/s007950200009 · Cited by 75 · see citing works
Endothelin-1 upregulation mediates aging-related cardiac fibrosis
Wang, X., Guo, Z., Ding, Z., Khaidakov, M., Lin, J., Xu, Z., Sharma, S. G., Jiwani, S. S., & Mehta, J. L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.001 · Cited by 72 · see citing works
Waxman, A. B., & Zamanian, R. T. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.002 · Cited by 71 · see citing works
Endothelin in Pulmonary Fibrosis
Fonseca, C., Abraham, D., & Renzoni, E. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0388tr · Cited by 71 · see citing works
Fraccarollo, D., Galuppo, P., Bauersachs, J. K., & Ertl, G. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00256-0 · Cited by 68 · see citing works
Tinazzi, E., Puccetti, A., Patuzzo, G., Barbieri, A., Argentino, G., Federico, C., Dolcino, M., Beri, R., Marchi, G., Ottria, A., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/147616 · Cited by 66 · see citing works
Álvarez, D., Briassouli, P., Clancy, R. M., Zavadil, J., Reed, J. H., Abellar, R. G., Halushka, M. K., Fox-Talbot, K., Barrat, F. J., & Buyon, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263657 · Cited by 66 · see citing works
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy
Henry, T. W., Mendoza, F. A., & Jiménez, S. A. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102396 · Cited by 66 · see citing works
Systemic sclerosis: the susceptible host (genetics and environment)
Tan, F. K. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00015-2 · Cited by 64 · see citing works
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 62 · see citing works
Pulmonary Arterial Hypertension in Systemic Sclerosis
Ramirez, A. M., & Varga, J. (2004) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200403060-00002 · Cited by 61 · see citing works
Looking to the future: a new decade of pulmonary arterial hypertension therapy
McLaughlin, V. V. (2011) · European Respiratory Review · doi:10.1183/09059180.00006411 · Cited by 59 · see citing works
Endothelial-to-mesenchymal transition in systemic sclerosis
Benedetto, P. D., Ruscitti, P., Berardicurti, O., Vomero, M., Navarini, L., Dolo, V., Cipriani, P., & Giacomelli, R. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13599 · Cited by 57 · see citing works
Endothelin axis polymorphisms in patients with scleroderma
Fonseca, C., Renzoni, E. A., Sestini, P., Pantelidis, P., Lagan, A. L., Bunn, C., McHugh, N. J., Welsh, K. I., du Bois, R. M., Denton, C. P., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22036 · Cited by 56 · see citing works
Serum galectin-3 level in systemic sclerosis
Koca, S. S., Akbas, F., Özgen, M., Yolbaş, S., İlhan, N., Gündoğdu, B., & Işık, A. T. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2346-8 · Cited by 55 · see citing works
Kissin, E. Y., & Korn, J. H. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00018-8 · Cited by 53 · see citing works
Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
Price, L., & Howard, L. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808030-00004 · Cited by 54 · see citing works
Fibroblast and endothelial apoptosis in systemic sclerosis
Jun, J., Kuechle, M. K., Harlan, J. M., & Elkon, K. B. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00012 · Cited by 54 · see citing works
Endothelin‐1 stimulates colon cancer adjacent fibroblasts
Knowles, J. P., Shiwen, X., Haque, S., Bhalla, A., Dashwood, M. R., Yang, S., Taylor, I., Winslet, M. C., Abraham, D., & Loizidou, M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26090 · Cited by 52 · see citing works
Busch, W., Kühnel, D., Schirmer, K., & Scholz, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-65 · Cited by 52 · see citing works
Gilbane, A. J., Derrett‐Smith, E. C., Trinder, S. L., Good, R. B., Pearce, A. C., Denton, C. P., & Holmes, A. M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1464oc · Cited by 48 · see citing works
Davie, N. J., SCHERMULY, R. T., Weißmann, N., Grimminger, F., & Ghofrani, H. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02120.x · Cited by 48 · see citing works
Soldano, S., Montagna, P., Villaggio, B., Parodi, A., Gianotti, G., Sulli, A., SERIOLO, B., Secchi, M. E., & Cutolo, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.097378 · Cited by 48 · see citing works
Cytokine directed therapy in scleroderma: rationale, current status, and the future
Simms, R. W., & Korn, J. H. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200211000-00015 · Cited by 48 · see citing works
Update on pathophysiology of scleroderma with special reference to immunoinflammatory events
Chizzolini, C. (2006) · Annals of Medicine · doi:10.1080/07853890601098152 · Cited by 48 · see citing works
Vascular Changes in Bleomycin-Induced Scleroderma
Yamamoto, T., & Katayama, I. (2011) · International Journal of Rheumatology · doi:10.1155/2011/270938 · Cited by 46 · see citing works
Scleroderma, fibroblasts, signaling, and excessive extracellular matrix
Ihn, H. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0069-9 · Cited by 46 · see citing works
Raghu, G., King, T. E., Behr, J., Brown, K. K., du Bois, R. M., Leconte, I., Roux, S., & Swigris, J. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00188108 · Cited by 45 · see citing works
Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy
Thannickal, V. J., Flaherty, K. R., Martínez, F. J., & Lynch, J. P. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.8.1671 · Cited by 44 · see citing works
Ahearne, M., Liu, K., Haj, A. J. E., Then, K. Y., Rauz, S., & Yang, Y. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2008.0650 · Cited by 44 · see citing works
Connective tissue associated pulmonary arterial hypertension
Coghlan, G., & Handler, C. E. (2006) · Lupus · doi:10.1191/0961203306lu2280rr · Cited by 44 · see citing works
Mast cells and collagen fibrillogenesis
Atiakshin, D., Buchwalow, I., & Tiemann, M. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01875-9 · Cited by 43 · see citing works
Rokni, M., Shaker, M. S., Kavosi, H., Shokoofi, S., Mahmoudi, M., & Farhadi, E. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02787-w · Cited by 41 · see citing works
Endothelin Receptor Antagonists
Clozel, M., Maresta, A., & Humbert, M. J. C. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-38664-0_9 · Cited by 40 · see citing works
Endothelin-1 mediated regulation of extracellular matrix collagens in cells of human lamina cribrosa
Rao, V. R., Krishnamoorthy, R. R., & Yorio, T. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.03.003 · Cited by 40 · see citing works
Wang, X., Liu, Y., Chun, Q., & Lu, S. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.08.007 · Cited by 40 · see citing works
Endothelin and endothelin receptor antagonism in portopulmonary hypertension
Neuhofer, W., Gülberg, V., & Gerbes, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01690.x · Cited by 39 · see citing works
Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases
Cozzi, F., Montisci, R., Marotta, H., Bobbo, F., Durigon, N., Ruscazio, M., Sfriso, P., Iliceto, S., & Todesco, S. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01684.x · Cited by 38 · see citing works
Molecular mechanisms of endothelial remodeling under doxorubicin treatment
Podyacheva, E., Danilchuk, M., & Toropova, Y. G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114576 · Cited by 37 · see citing works
Akamata, K., Asano, Y., Aozasa, N., Noda, S., Taniguchi, T., Takahashi, T., Ichimura, Y., Toyama, T., & Sato, S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4529 · Cited by 37 · see citing works
Volpini, R. A., Costa, R. S., da Silva, C. G. A., & Coimbra, T. M. (2004) · Nephron Physiology · doi:10.1159/000081558 · Cited by 37 · see citing works
Lynch, J. P., Fishbein, M. C., Saggar, R., Zisman, D. A., & Belperio, J. A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.3.377 · Cited by 37 · see citing works
The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis
Leask, A. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.011 · Cited by 36 · see citing works
Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy
Nagasawa, H., Ueda, S., Suzuki, H., Jenkinson, C. P., Fukao, Y., Nakayama, M., Otsuka, T., Okuma, T., Clapper, W., Liu, K., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae021 · Cited by 35 · see citing works
Trow, T. K., & Taichman, D. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.02.016 · Cited by 35 · see citing works
- Authors
- Shi-wen, X., Denton, C. P., Holmes, A. M., Black, C. M., Abraham, D. J., Dashwood, M. R., Bou-Gharios, G., & Pearson, J. D.
- Affiliations
- The Royal Free Hospital (GB)
- King's College London (GB)
- Corresponding author
- Abraham, David J.
- Venue
- Journal of Investigative Dermatology
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 116
- Issue
- 3
- Pages
- 417-425
- ISSN
- 0022-202X (ISSN-L)
- OpenAlex
- W2064485592
- Cited by
- 243
- References
- 35
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 6
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of Investigative Dermatology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- endothelin-1, systemic sclerosis, fibroblasts, extracellular matrix remodeling, collagen synthesis, type I collagen, type III collagen, fibronectin, MMP-1, ETA receptor, endothelin B receptor, connective tissue fibrosis, tyrosine kinase inhibitors, protein kinase C
- MeSH terms
- Cells, Cultured, Collagen, Connective Tissue, Extracellular Matrix, Fibroblasts, Humans, Reference Values, RNA, Messenger, Scleroderma, Systemic, Transcription, Genetic, Gene Expression, Receptors, Endothelin, Endothelin-1, Matrix Metalloproteinase 1, Receptor, Endothelin A, Receptor, Endothelin B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review